Volume 22, Number 5—May 2016
Research
Outbreak of Middle East Respiratory Syndrome at Tertiary Care Hospital, Jeddah, Saudi Arabia, 2014
Table 2
Date | Setting where treated | Incubation period, d | Probability |
---|---|---|---|
Mar 24 | ED | 9† | 0.0578‡ |
Mar 25 | ED | 8 | 0.0396§ |
Mar 25 | Inpatient | 8 | 0.0396§ |
Mar 26 | Dialysis | 7 | 0.0530 |
Mar 26 | Inpatient | 7 | 0.0530 |
Mar 27 | Inpatient | 6 | 0.1358 |
Mar 28 | Dialysis | 5 | 0.0800 |
Mar 29 | Inpatient | 5 | 0.0800 |
Mar 29 | Dialysis | 4 | 0.0803 |
Mar 29 | Inpatient | 4 | 0.0803 |
Mar 30 | Inpatient | 3 | 0.1141 |
*Data are from patient 5 (Figure 1). The total probability is 0.50 for inpatient, 0.21 for the dialysis unit, and 0.10 for ED, so acquisition most probably occurred in the inpatient areas. ED, emergency department.
†Represents the incubation period if date of disease acquisition was March 24 and disease onset was April 2.
‡Represents the probability of an incubation period of 9 days (Table 1).
§Patient was treated in 2 settings on March 25, so probability is half of the probability for each setting.
1These authors contributed equally to this article.
2Current affiliation: International Medical Center, Jeddah, Saudi Arabia.
3Current affiliation: Pfizer Inc., Collegeville, Pennsylvania, USA.
Page created: April 13, 2016
Page updated: April 13, 2016
Page reviewed: April 13, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.